4th Bacteriophage Therapy Summit
Evvnt Promotion / evvnt
Archivio
14.02.2022 - 16.02.2022 Online
Time: 09:00 to 17:00
Temi della conferenza
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development. Are you ready to gain the insights needed to radically transform your bacteriophage therapies into commercially viable products?
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development. Are you ready to gain the insights needed to radically transform your bacteriophage therapies into commercially viable products?
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/923318-3?pid=4832
Speakers: Bob Blasdel, Research Director, Vesale Pharma , Cara Fiore, Microbiologist, FDA Office of Vaccines Research and Review , and more.
Brochure: https://go.evvnt.com/923318-3?pid=4832
Speakers: Bob Blasdel, Research Director, Vesale Pharma , Cara Fiore, Microbiologist, FDA Office of Vaccines Research and Review , and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/923318-2?pid=4832
Mr. Customer Service
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
